Metraipolis › archive › dc_9cd758485ab5

Graft-versus-tumor effect — Wikipedia (en)

Source
Wikipedia (en)
Original
https://en.wikipedia.org/wiki/Graft-versus-tumor_effect
License (as archived)
CC-BY-SA-4.0
Archived
2026-10-07T14:55:41.031Z
SHA-256 of the archived text
707d1a331b3fcd2a61eb4070b206d34c2cdd53ed32fc7b4b52542e4e84498f38
Stable URL of this page
https://metraipolis.com/documento/dc_9cd758485ab5

How to cite

Graft-versus-tumor effect — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Graft-versus-tumor_effect (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_9cd758485ab5 (Metraipolis archive dc_9cd758485ab5, sha256 707d1a331b3fcd2a61eb4070b206d34c2cdd53ed32fc7b4b52542e4e84498f38)
BibTeX
@misc{dc9cd758485ab5,
  title = {Graft-versus-tumor effect — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/Graft-versus-tumor_effect},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_9cd758485ab5; sha256 707d1a331b3fcd2a61eb4070b206d34c2cdd53ed32fc7b4b52542e4e84498f38},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Graft-versus-tumor_effect. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Graft-versus-tumor effect (GvT) appears after allogeneic hematopoietic stem cell transplantation (HSCT). The graft contains donor T cells (T lymphocytes) that can be beneficial for the recipient by eliminating residual malignant cells. GvT might develop after recognizing tumor-specific or recipient-specific alloantigens. It could lead to remission or immune control of hematologic malignancies. This effect applies in myeloma and lymphoid leukemias, lymphoma, multiple myeloma and possibly breast cancer. It is closely linked with graft-versus-host disease (GvHD), as the underlying principle of alloimmunity is the same. CD4+CD25+ regulatory T cells (Treg) can be used to suppress GvHD without loss of beneficial GvT effect. The biology of GvT response is still not fully understood but it is probable that the reaction with polymorphic minor histocompatibility antigens expressed either specifically on hematopoietic cells or more widely on a number of tissue cells or tumor-associated antigens is involved. This response is mediated largely by cytotoxic T lymphocytes (CTL) but it can be employed by natural killers (NK cells) as separate effectors, particularly in T-cell-depleted HLA-haploidentical HSCT.

Tema degli esploratori: scienze della vita e salute (deposito sistematico; categoria «Immunology»).
Fonte: Wikipedia in inglese, voce «Graft-versus-tumor effect» — https://en.wikipedia.org/wiki/Graft-versus-tumor_effect
Wikidata Q17144616: «immunological rejection of tumor tissue or cells following bone marrow transplantation» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q17144616
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Graft-versus-tumor_effect?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1335665831, consultata il 2026-10-07T14:28:54.702Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 030ce392e3a4b46cf7be4846ea57d6657aa5bf088d878ce8788b52227d92c995